15:53 Jun 12

Mankind Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2381.10
+8.40 (+0.35%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Mankind Pharma Ltd. Financials

Mankind Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2381.10
+8.40 (+0.35%)
15:53 Jun 12
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

29/100
Expensive Valuation

Technical

57/100
Technically Neutral

Strength

5

Weakness

6

Opportunity

1

Threats

0

11.73 %

ROE %

6.81 %

ROA %

46.32

EPS

394.87

BVPS

13.39 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
7781.56 8749.43 10334.77 12207.44 14277.64
Operating Expenses +
5792.2 6848.79 7799.71 9189.51 10660.23
Raw Material
2871.31 2622.9 3263.37 3672.04 4016
Increase Decrease in Cost
-449.59 290.74 -53.67 -183 36.12
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1620.59 1918.47 2274.73 2692.37 3183.9
Miscellaneous Expenses
3377.39 3635.16 5134.98 6319.48 6880.15
Operating Profit
1989.36 1900.64 2535.06 3017.93 3617.41
Other Income
196.03 128.57 280.86 536.79 358.79
Depreciation
166.62 325.92 398.25 621.22 886.18
Interest
58.61 44.47 33.53 429.41 639.28
Profit before tax and exceptio..
1960.15 1658.81 2384.14 2504.09 2450.74
Exceptional Items
0 0 0 0 -129.75
PBT
1960.15 1658.81 2384.14 2504.09 2320.99
Provision for Taxation
521.64 361.56 457.59 509.74 394.58
Net Profit
1438.51 1297.25 1926.56 1998.88 1926.41
NET Profit after MI
1433.48 1281.86 1912.9 1990.96 1912.93
EPS
35.78 32 47.68 49.2 46.35
Operating Profit Margin (%)
25.57 21.72 24.53 24.72 25.34
Net Profit Margin (%)
18.42 14.65 18.51 16.31 13.4

Mankind Pharma Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 72.70 72.70 72.70 72.70 72.70 72.70
FII 10.20 11.30 12.80 13.10 12.90 13.30
Public 14.50 13.30 11.90 11.50 11.50 11.10
Others 2.60 2.70 2.60 2.70 2.90 2.90
Shareholder Shares Holding %
Download Our App On: